Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

This article first appeared on GuruFocus. Aurora Cannabis Inc (TSX:ACB) is set to release its Q2 2026 earnings on Nov 5, 2025 ...

Aurora Cannabis reports Q2-2026 revenue growth with stronger international sales but posts net loss and negative free cash flow. Learn why ACB stock is a hold.

Aurora Cannabis (ACB) delivered earnings and revenue surprises of +200.00% and +2.88%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Atco combines regulated utilities, essential infrastructure, and conservative management into a low-drama, buy-and-hold stock ...

Aurora Cannabis Inc. is rated a Buy with 40% upside in current levels and expects solid growth in medical cannabis sales.

Looking ahead, Aurora expects its third-quarter 2026 consolidated revenue to increase year over year, led by 8% to 12% growth in global medical cannabis sales. Management also projects continued ...

Gold price today November 13, 2025 increased sharply, SJC gold bar price and plain rings increased simultaneously by nearly 2 ...

The U.S. stock market fell as Nvidia and other superstars created by the frenzy around artificial-intelligence technology ...

Vingroup group accelerates, VN-Index increases beyond 1,630 points; Ho Chi Minh City: Newly established enterprises decrease ...